Badrul Chowdhury
Corporate Officer/Principal chez PHILIP MORRIS INTERNATIONAL, INC.
Profil
Badrul A.
Chowdhury is currently the Chief Life Sciences Officer at Philip Morris International, Inc. He previously worked at the US Food & Drug Administration as the Director-Pulmonary, Allergy & Rheumatology Product from 2002 to 2018.
He also worked as the Senior VP-Research & Development at MedImmune LLC from 2018 to 2019, and as the Chief Medical Officer at Savara, Inc. from 2019 to 2022.
Additionally, he served as an Independent Director at Proteostasis Therapeutics, Inc. from 2019 to 2020, and as the Senior Vice President at AstraZeneca PLC in 2019.
Chowdhury holds a doctorate degree from Memorial University of Newfoundland and undergraduate and graduate degrees from Dhaka Medical College.
Postes actifs de Badrul Chowdhury
| Sociétés | Poste | Début |
|---|---|---|
| PHILIP MORRIS INTERNATIONAL, INC. | Corporate Officer/Principal | 14/09/2022 |
Anciens postes connus de Badrul Chowdhury
| Sociétés | Poste | Fin |
|---|---|---|
| SAVARA INC. | Chief Tech/Sci/R&D Officer | 09/09/2022 |
| PROTEOSTASIS THERAPEUTICS, INC. | Director/Board Member | 01/12/2020 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/11/2019 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | 01/04/2019 |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Corporate Officer/Principal | 01/04/2018 |
Formation de Badrul Chowdhury
| Memorial University of Newfoundland | Doctorate Degree |
| Dhaka Medical College | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| PHILIP MORRIS INTERNATIONAL, INC. | Consumer Non-Durables |
| SAVARA INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Government |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
